Pierre Stéphan

机构：Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute, Hôpital Saint-Louis, Dana-Farber Brigham Cancer Center · ORCID：0000-0001-5999-284X

发表论文 62 篇 · 总被引 50 次 · h-index 4

代表论文

• TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas (2025 · Blood Advances · 被引 4)
• Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment (2026 · Cell Reports Medicine)
• Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma? (2026 · Bone Marrow Transplantation)
• 1246 Novel Anti-Chimeric Antigen Receptor T-cell Antibody Enables In Situ Assessment of CAR-T Cell Distribution and Study of Tumor Microenvironment of Post-CAR-T Relapsed/Refractory Diffuse Large B-cell Lymphomas (2026 · Laboratory Investigation)
• Outcomes of CD20 Bispecific Antibodies after CD19 CAR T-cell Therapy in mantle cell lymphoma: A Multicenter Analysis from the Collaborative U.S. Bispecific Consortium (CUBIC) (2026 · Transplantation and Cellular Therapy)
• Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma? (2026 · Bone Marrow Transplantation)